There are 2934 resources available
Poster Discussion – Genitourinary tumours, prostate - Invited Discussant LBA50, 845PD, 846PD and 847PD
Presenter: Elena Castro
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Slides
Webcast
Discussion led by Chair
Presenter: Javier Puente
Session: Specificity of upper tract urothelial carcinoma biology and management
Resources:
Slides
Webcast
Presentation of case/condition
Presenter: John Haanen
Session: Toxicity profiling of immunotherapy of cancer
Resources:
Slides
Webcast
Life-threatening immune toxicities
Presenter: Stephane Champiat
Session: Toxicity profiling of immunotherapy of cancer
Resources:
Slides
Webcast
Presentation of case/condition
Presenter: John Haanen
Session: Toxicity profiling of immunotherapy of cancer
Resources:
Slides
Webcast
Managing patients with irAEs unresponsive to corticosteroids
Presenter: Camillo Ribi
Session: Toxicity profiling of immunotherapy of cancer
Resources:
Slides
Webcast
1085 - CCTG IND 232: A Phase II Study of Durvalumab With or Without Tremelimumab in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
Presenter: Sebastien Hotte
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Abstract
1612 - Efficacy and Safety of Nivolumab in Combination With Docetaxel in Men With Metastatic Castration-Resistant Prostate Cancer in CheckMate 9KD
Presenter: Karim Fizazi
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Abstract
Poster Discussion – Genitourinary tumours, prostate - Invited Discussant LBA51, LBA52, 848PD, 849PD and 855PD
Presenter: Cora Sternberg
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Slides
Webcast
5387 - Health-related quality of life (HRQL) in a randomized phase 3 trial of enzalutamide with standard first line therapy for metastatic, hormone-sensitive prostate cancer (mHSPC): ENZAMET (ANZUP 1304), an ANZUP-led, international, co-operative group trial
Presenter: Martin Stockler
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Abstract